Dr Stefan Rauh works as a medical oncologist/haematologist at the Centre Hospitalier Emile Mayrisch (CHEM), Differdange and Esch in Luxembourg.
Born 1964 in Munich, Germany, he studied Medicine in Munich and Lausanne, Switzerland, followed by post-graduate training in Munich, Nancy, France and Luxembourg.
In 1999, he was given the opportunity to develop an oncology unit (including out-patient hospital and palliative unit) at Differdange Regional Hospital. In 2010 the hospital merged with Esch, making a total of 500 beds. He is now part of the CHEM oncology unit with palliative care and President of CHEM’s Plateform Cancer.
His work is mainly clinical, however his work also includes teaching and clinical research activity and he is interested in co-operations with developing countries.
At present, he serves as a tutor and lecturer at the General Medicine Faculty of the University of Luxembourg.
He is currently involved in eight international clinical phase 3 and 4 studies, and has developed prospective randomised studies in out patient symptom monitoring in Luxembourg (pro-elects). Studies involve the CRP Santé, CIEC and IBBL, some are in collaboration with the CHL.
Dr Rauh is Vice President of the Société Luxembourgeoise d’Oncology and a member of the National Tumor Registry’s board, the National Plan Cancer, the Luxembourg National Cancer Center Project and of the Scientific Council of the National Social Security.
Dr Rauh served as the ESMO National Representative for Luxembourg for eight years and had a seat on the ESMO Executive Board for the 2015-2016 term of office. From 2015, he is the Chair of the ESMO Practising Oncologists Working Group. In addition, he is an extended member of the ESMO Public Policy Working Group.
He is also a member of ASCO, ASH and a volunteer of Health Volunteers Overseas.